HJC-0123
Product Specifications
CAS Number
1430420-02-2
Target
Apoptosis|||STAT|||Others|||Interleukin|||TGF-beta/Smad
Related Pathways
JAK/STAT signaling|||Apoptosis|||Immunology/Inflammation|||Others|||Stem Cells
Bioactivity
Downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values. Furthermore, HJC-0123 significantly suppressed estrogen receptor (ER) -negative breast cancer MDA-MB-231 xenograft tumor growth in vivo (p.o.), indicating its great potential as an efficacious and orally bioavailable drug candidate for human cancer therapy.
Smiles
C(NC=1C=C2C(=CC1)C=CS2(=O)=O)(=O)C=3C4=C(N=C(C3)C5=CC=CC=C5)C=CC=C4
Molecular Formula
C24H16N2O3S
Molecular Weight
412.46
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
038275-ML550 100 µL
MCL1, BH3 Domain Specific (MCL1, BCL2L3, Induced myeloid leukemia cell differentiation protein Mcl-1, Bcl-2-like protein 3, Bcl-2-related protein EAT/mcl1, mcl1/EAT) (MaxLight 550) discontinued
Ask
View Details